Gary R. Fanger

4.9k total citations · 1 hit paper
55 papers, 4.0k citations indexed

About

Gary R. Fanger is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gary R. Fanger has authored 55 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Gary R. Fanger's work include Epigenetics and DNA Methylation (8 papers), Melanoma and MAPK Pathways (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Gary R. Fanger is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Melanoma and MAPK Pathways (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Gary R. Fanger collaborates with scholars based in United States, United Kingdom and Japan. Gary R. Fanger's co-authors include Gary L. Johnson, Christian Widmann, Bruce A. Woda, Zhong Jiang, Matthew Jarpe, Karen Dresser, Pär Gerwins, Jiangchun Xu, Bryan Oronsky and Kenneth L. Rock and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gary R. Fanger

54 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy

2021 241 citations Matthew E. Griffin, Juliel Espinosa et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary R. Fanger United States	31	2.5k	954	800	769	599	55	4.0k
David J. Mulholland United States	28	2.9k 1.2×	1.2k 1.2×	1.2k 1.5×	937 1.2×	329 0.5×	50	4.4k
Ming‐Fong Lin United States	37	2.5k 1.0×	938 1.0×	1.6k 2.0×	748 1.0×	327 0.5×	100	4.1k
Maréne Landström Sweden	32	3.2k 1.3×	1.3k 1.3×	553 0.7×	1.0k 1.3×	493 0.8×	81	4.7k
Isidro Sánchez‐García Spain	36	2.7k 1.1×	1.3k 1.4×	454 0.6×	669 0.9×	461 0.8×	115	4.4k
Jean Mosser France	39	2.8k 1.1×	860 0.9×	551 0.7×	658 0.9×	536 0.9×	115	5.1k
John D. Hooper Australia	35	1.9k 0.8×	1.1k 1.1×	468 0.6×	1.1k 1.4×	406 0.7×	120	4.1k
Stéphane Terry France	33	1.6k 0.7×	1.1k 1.2×	1.4k 1.7×	1.1k 1.4×	650 1.1×	68	3.6k
Eric Chastre France	33	2.5k 1.0×	1.0k 1.1×	305 0.4×	548 0.7×	263 0.4×	92	4.1k
Youyong Lu China	35	2.8k 1.1×	1.4k 1.4×	443 0.6×	1.5k 2.0×	358 0.6×	122	4.4k

Countries citing papers authored by Gary R. Fanger

Since Specialization

Citations

This map shows the geographic impact of Gary R. Fanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Fanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Fanger more than expected).

Fields of papers citing papers by Gary R. Fanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Fanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Fanger. The network helps show where Gary R. Fanger may publish in the future.

Co-authorship network of co-authors of Gary R. Fanger

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Fanger. A scholar is included among the top collaborators of Gary R. Fanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Fanger. Gary R. Fanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akgül, Ali, Massimo Maddaloni, Carol Hoffman, et al.. (2023). Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease. Scientific Reports. 13(1). 19489–19489. 3 indexed citations

Griffin, Matthew E., Juliel Espinosa, Ji‐Dung Luo, et al.. (2021). Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science. 373(6558). 1040–1046. 241 indexed citations breakdown →

Arukha, Ananta Prasad, Meerambika Mishra, Jyoti K. Jha, et al.. (2021). Lactococcus lactis Delivery of Surface Layer Protein A Protects Mice from Colitis by Re-Setting Host Immune Repertoire. Biomedicines. 9(9). 1098–1098. 8 indexed citations

Fanger, Gary R., Robert A. Maue, Leslie Henderson, Joel S. Tabb, & Elizabeth Wilson. (2021). Suppression of sodium channel function in differentiating C2 muscle cells stably overexpressing rat androgen receptors. UNC Libraries.

Oronsky, Bryan, Gary R. Fanger, Neil Oronsky, Susan J. Knox, & Jan Scicinski. (2014). The Implications of Hyponitroxia in Cancer. Translational Oncology. 7(2). 167–173. 23 indexed citations

Yantiss, Rhonda K., Bruce A. Woda, Gary R. Fanger, et al.. (2005). KOC (K Homology Domain Containing Protein Overexpressed in Cancer). The American Journal of Surgical Pathology. 29(2). 188–195. 139 indexed citations

Stolk, John A., David A Molesh, Patricia D. McNeill, et al.. (2005). VSGP/F-Spondin: A New Ovarian Cancer Marker. Tumor Biology. 26(5). 245–257. 23 indexed citations

Kalos, Michael, Jon Askaa, Bonnie L. Hylander, et al.. (2004). Prostein expression is highly restricted to normal and malignant prostate tissues. The Prostate. 60(3). 246–256. 61 indexed citations

Wang, Aijun, et al.. (2003). A novel method for increasing the expression level of recombinant proteins. Protein Expression and Purification. 30(1). 124–133. 11 indexed citations

10.

Jiang, Zhong, Gary R. Fanger, Bruce A. Woda, et al.. (2003). Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Human Pathology. 34(8). 792–796. 144 indexed citations

11.

Fan, Liqing, Yoshihiro Watanabe, Patricia D. McNeill, et al.. (2003). L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. British Journal of Cancer. 88(6). 887–894. 89 indexed citations

12.

Carter, Darrick, Davin C. Dillon, Lisa D. Reynolds, et al.. (2003). Serum antibodies to lipophilin B detected in late stage breast cancer patients.. PubMed. 9(2). 749–54. 17 indexed citations

13.

Foy, Teresa M., Gary R. Fanger, Susan L. Hand, et al.. (2002). Designing HER2 vaccines. Seminars in Oncology. 29(3). 53–61. 29 indexed citations

14.

Foy, Teresa M., et al.. (2002). Designing HER2 vaccines. Seminars in Oncology. 29(3 Suppl 11). 53–61. 19 indexed citations

15.

Yang, Ximing J., Chin‐Lee Wu, Bruce A. Woda, et al.. (2002). Expression of α-Methylacyl-CoA Racemase (P504S) in Atypical Adenomatous Hyperplasia of the Prostate. The American Journal of Surgical Pathology. 26(7). 921–925. 100 indexed citations

16.

Wang, Tongtong, Deborah Hopkins, Li-Qun Fan, et al.. (2001). A p53 homologue and a novel serine proteinase inhibitor are over-expressed in lung squamous cell carcinoma. Lung Cancer. 34(3). 363–374. 6 indexed citations

17.

Schaefer, Brian C., Margaret F. Ware, Philippa Marrack, et al.. (1999). Live Cell Fluorescence Imaging of T Cell MEKK2. Immunity. 11(4). 411–421. 49 indexed citations

18.

Fanger, Gary R., et al.. (1998). 14-3-3 Proteins Interact with Specific MEK Kinases. Journal of Biological Chemistry. 273(6). 3476–3483. 133 indexed citations

19.

Smith, Martin A., et al.. (1997). Selective Regulation of Agrin mRNA Induction and Alternative Splicing in PC12 Cells by Ras-dependent Actions of Nerve Growth Factor. Journal of Biological Chemistry. 272(25). 15675–15681. 30 indexed citations

20.

Fanger, Gary R.. (1997). MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. The EMBO Journal. 16(16). 4961–4972. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact